Published in Infection on October 01, 2002
Expression of an additional cathelicidin antimicrobial peptide protects against bacterial skin infection. Proc Natl Acad Sci U S A (2005) 1.26
Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum (1994) 14.16
Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization. Kidney Int (1998) 4.31
Hantavirus infection presenting as acute renal failure. Lancet (1990) 2.40
A nanogram dose of the CYP3A probe substrate midazolam to evaluate drug interactions. Clin Pharmacol Ther (2013) 2.15
High interlaboratory reproducibility of matrix-assisted laser desorption ionization-time of flight mass spectrometry-based species identification of nonfermenting bacteria. J Clin Microbiol (2009) 2.13
Influence of test technique on sensitization status of patients on the kidney transplant waiting list. Am J Transplant (2013) 2.12
Evaluation of BBL CHROMagar orientation medium for detection and presumptive identification of urinary tract pathogens. J Clin Microbiol (1997) 2.06
"False-positive" anti-neutrophil cytoplasmic antibodies in HIV infection. Lancet (1990) 1.94
The value of indirect immunofluorescence and solid phase techniques for ANCA detection. A report on the first phase of an international cooperative study on the standardization of ANCA assays. EEC/BCR Group for ANCA Assay Standardization. J Immunol Methods (1993) 1.86
[Clinical pharmacology of ofloxacin: a new chemotherapeutic agent belonging to the gyrase inhibitor group]. Infection (1986) 1.85
Safety of ultrasound-guided percutaneous renal biopsy-retrospective analysis of 1090 consecutive cases. Nephrol Dial Transplant (1998) 1.71
Gabapentin enhances the analgesic effect of morphine in healthy volunteers. Anesth Analg (2000) 1.71
Elevated levels of markers of endothelial cell damage and markers of activated coagulation in patients with systemic necrotizing vasculitis. Thromb Haemost (1996) 1.71
Assessment of the predictive power of genotypes for the in-vivo catalytic function of CYP2D6 in a German population. Pharmacogenetics (1998) 1.64
Evidence for impaired hepatic vitamin K1 metabolism in patients treated with N-methyl-thiotetrazole cephalosporins. Thromb Haemost (1984) 1.59
Applicability of robot-assisted laparoscopic radical prostatectomy in renal allograft recipients. Transplant Proc (2012) 1.58
Same incidence of adverse drug events after codeine administration irrespective of the genetically determined differences in morphine formation. Pain (1998) 1.52
Serum procalcitonin levels in bacterial and abacterial meningitis. Crit Care Med (2000) 1.52
Spread of ampicillin/vancomycin-resistant Enterococcus faecium of the epidemic-virulent clonal complex-17 carrying the genes esp and hyl in German hospitals. Eur J Clin Microbiol Infect Dis (2005) 1.51
In situ production of TNF-alpha, IL-1 beta and IL-2R in ANCA-positive glomerulonephritis. Kidney Int (1993) 1.49
Tissue factor antigen is elevated in patients with microvascular complications of diabetes mellitus. Exp Clin Endocrinol Diabetes (1997) 1.48
Rapidly progressive IgA nephropathy with anti-myeloperoxidase antibodies benefits from immunosuppression. Clin Nephrol (1997) 1.48
Differentiation of polymorphonuclear neutrophils in patients with systemic infections and chronic inflammatory diseases: evidence of prolonged life span and de novo synthesis of fibronectin. J Mol Med (Berl) (2000) 1.47
Pharmacokinetics of oral and intravenous rifampicin during chronic administration. Klin Wochenschr (1985) 1.46
Improved clinical outcome of lupus nephritis during the past decade: importance of early diagnosis and treatment. Ann Rheum Dis (2003) 1.44
Genesis and significance of hypertension in autosomal dominant polycystic kidney disease. Nephron (1994) 1.42
Is there a genetic factor in flecainide toxicity? BMJ (1988) 1.41
Rapidly progressive glomerulonephritis in a patient with Henoch-Schoenlein purpura. Spontaneous recovery of renal function after six months of maintenance hemodialysis. Clin Nephrol (1995) 1.39
Polymorphonuclear neutrophils as accessory cells for T-cell activation: major histocompatibility complex class II restricted antigen-dependent induction of T-cell proliferation. Immunology (2000) 1.39
CAPD: developments during changing times. Perit Dial Int (2009) 1.38
Reduction in non-glomerular renal clearance of the caffeine metabolite 1-methylxanthine by probenecid. Int J Clin Pharmacol Ther (2007) 1.38
Prevention of p.o. clotting of av. cimino fistulae with acetylsalicyl acid. Results of a prospective double blind study. Klin Wochenschr (1974) 1.34
Polymorphonuclear neutrophils in Wegener's granulomatosis acquire characteristics of antigen presenting cells. Kidney Int (2001) 1.30
Pharmacokinetics of (+)-, (-)- and (+/-)-verapamil after intravenous administration. Br J Clin Pharmacol (1984) 1.30
Seroprevalence of hantavirus antibodies in Germany as determined by a new recombinant enzyme immunoassay. Eur J Clin Microbiol Infect Dis (1995) 1.28
Diagnostic significance of anticytoplasmatic antibodies (ACPA/ANCA) in detection of Wegener's granulomatosis and other forms of vasculitis. Nephron (1988) 1.27
Renal functional reserve in healthy elderly subjects. J Am Soc Nephrol (1993) 1.24
The influence of CYP2D6 polymorphism and quinidine on the disposition and antitussive effect of dextromethorphan in humans. Clin Pharmacol Ther (1996) 1.24
Necrotizing dermatitis resulting from hemodialysis with polyvinylchloride tubing. Ann Intern Med (1979) 1.21
Acute renal failure, hypertension and skin necrosis in a patient with streptokinase therapy. Am J Nephrol (1984) 1.20
Is vasculitis in subacute bacterial endocarditis associated with ANCA? Lancet (1991) 1.20
The first 5 years of the family clinic for HIV at Tygerberg Hospital: family demographics, survival of children and early impact of antiretroviral therapy. J Trop Pediatr (2005) 1.18
Mechanism of cephalosporin-induced hypoprothrombinemia: relation to cephalosporin side chain, vitamin K metabolism, and vitamin K status. J Clin Pharmacol (1988) 1.17
Pharmacokinetics of midazolam in relation to polymorphic sparteine oxidation. Br J Clin Pharmacol (1986) 1.14
Naltrexone does not relieve uremic pruritus: results of a randomized, double-blind, placebo-controlled crossover study. J Am Soc Nephrol (2000) 1.12
Transdifferentiation of polymorphonuclear neutrophils: acquisition of CD83 and other functional characteristics of dendritic cells. J Mol Med (Berl) (2001) 1.11
Arteriolar wall thickening, capillary rarefaction and interstitial fibrosis in the heart of rats with renal failure:the effects of ramipril, nifedipine and moxonidine. J Am Soc Nephrol (1996) 1.10
Development and standardization of solid phase assays for the detection of anti-neutrophil cytoplasmic antibodies (ANCA). A report on the second phase of an international cooperative study on the standardization of ANCA assays. J Immunol Methods (1996) 1.08
Podocytes are the major source of IL-1 alpha and IL-1 beta in human glomerulonephritides. Kidney Int (1997) 1.08
Is gender a determinant for evolution of renal failure? A study in autosomal dominant polycystic kidney disease. Am J Kidney Dis (1989) 1.07
Evaluation of a new chromogenic medium for the isolation and presumptive identification of Salmonella species from stool specimens. Eur J Clin Microbiol Infect Dis (2001) 1.07
[Integrated skills laboratory concept for undergraduate training in internal medicine]. Dtsch Med Wochenschr (2005) 1.05
Real-time contrast-enhanced sonography of renal transplant recipients predicts chronic allograft nephropathy. Am J Transplant (2006) 1.04
Expression of receptors for advanced glycosylated end-products in renal disease. Nephrol Dial Transplant (1995) 1.02
Hemostasis and thromboembolism in children with nephrotic syndrome: differences from adults. J Pediatr (1987) 1.02
T lymphocytes in patients with primary vasculitis: expansion of CD8+ T cells with the propensity to activate polymorphonuclear neutrophils. Rheumatology (Oxford) (2008) 1.02
Up-regulation of the dendritic cell marker CD83 on polymorphonuclear neutrophils (PMN): divergent expression in acute bacterial infections and chronic inflammatory disease. Clin Exp Immunol (2002) 1.02
The role of CYP2D6 in primary and secondary oxidative metabolism of dextromethorphan: in vitro studies using human liver microsomes. Br J Clin Pharmacol (1994) 1.01
Non-occlusive mesenteric infarction in dialysis patients: the importance of prevention and early intervention. Nephrol Dial Transplant (1995) 1.01
Bowel perforation with unused Tenckhoff catheters. Perit Dial Int (1989) 1.01
Hypercoagulability in the Nephrotic syndrome. Klin Wochenschr (1980) 1.00
Mycophenolate mofetil for maintenance therapy of Wegener's granulomatosis and microscopic polyangiitis: a pilot study in 11 patients with renal involvement. J Am Soc Nephrol (1999) 1.00
Color Doppler indices of renal allografts depend on vascular stiffness of the transplant recipients. Am J Transplant (2006) 1.00
Expression of major histocompatibility class II antigens on polymorphonuclear neutrophils in patients with Wegener's granulomatosis. Kidney Int (1999) 1.00
The influence of pharmacogenetics on opioid analgesia: studies with codeine and oxycodone in the Sprague-Dawley/Dark Agouti rat model. J Pharmacol Exp Ther (1994) 1.00
Cardiac biomarkers and survival in haemodialysis patients. Eur J Clin Invest (2007) 0.99
Multiple-dose pharmacokinetics of ofloxacin, a new broad-spectrum antimicrobial agent. Clin Ther (1986) 0.98
Meningeal involvement in Wegener's granulomatosis confirmed and monitored by positive circulating antineutrophil cytoplasm in cerebrospinal fluid. Neurology (1997) 0.97
Antineutrophil-cytoplasmic antibodies and antiglomerular basement membrane antibodies in Goodpasture's syndrome and in Wegener's granulomatosis. J Am Soc Nephrol (1992) 0.97
Penicillin-induced coagulation disorder. Lancet (1976) 0.96
Pharmacokinetics and metabolism of quinidine in extensive and poor metabolisers of sparteine. Eur J Clin Pharmacol (1986) 0.96
Wound complications following kidney and liver transplantation. Clin Transplant (2006) 0.95
Analysis of the CYP2D6 gene mutations and their consequences for enzyme function in a West African population. Pharmacogenetics (1999) 0.95
Platelet hyperaggregability as a consequence of the nephrotic syndrome. Thromb Res (1981) 0.94
Highly sensitive gas chromatographic-tandem mass spectrometric method for the determination of morphine and codeine in serum and urine in the femtomolar range. J Chromatogr B Biomed Sci Appl (1999) 0.93
SSA (Ro)-antibodies in Wegener's granulomatosis. Klin Wochenschr (1983) 0.93
Determining the time course of CYP3A inhibition by potent reversible and irreversible CYP3A inhibitors using A limited sampling strategy. Clin Pharmacol Ther (2011) 0.93
The spectrum of renal involvement in epidermolysis bullosa dystrophica hereditaria: report of two cases. Am J Kidney Dis (1988) 0.93
Thymoglobulin and ischemia reperfusion injury in kidney and liver transplantation. Nephrol Dial Transplant (2007) 0.92
Does the benzodiazepine antagonist Ro 15-1788 antagonize the action of ethanol? Br J Clin Pharmacol (1986) 0.92
CRP levels in autoimmune disease can be specified by measurement of procalcitonin. Infection (1999) 0.91
The role and value of sirolimus administration in kidney and liver transplantation. Clin Transplant (2006) 0.91
Sporadic cases of acute autochthonous hepatitis E virus infection in Southwest Germany. J Clin Virol (2009) 0.90
Review of the antiproliferative properties of mycophenolate mofetil in non-immune cells. Int J Clin Pharmacol Ther (2003) 0.90
Evaluation of a new selective medium, BD BBL CHROMagar MRSA II, for detection of methicillin-resistant Staphylococcus aureus in different specimens. J Clin Microbiol (2010) 0.90
Compassionate treatment of Wegener's granulomatosis with rabbit anti-thymocyte globulin. Clin Nephrol (1995) 0.90
Effect of ramipril, nifedipine, and moxonidine on glomerular morphology and podocyte structure in experimental renal failure. Nephrol Dial Transplant (1996) 0.90
Postinfectious glomerulonephritis--is there a link to alcoholism? Q J Med (1994) 0.89
Genetically determined differences in drug metabolism as a risk factor in drug toxicity. Toxicol Lett (1992) 0.89
Pregnancy-associated diseases are characterized by the composition of the systemic regulatory T cell (Treg) pool with distinct subsets of Tregs. Clin Exp Immunol (2012) 0.89
Four cases of sirolimus-associated interstitial pneumonitis: identification of risk factors. Transplant Proc (2007) 0.89
Pharmacokinetics and the pharmacodynamic action of midazolam in young and elderly patients undergoing tooth extraction. Clin Pharmacol Ther (1998) 0.89
[Drug-induced haemorrhagic diathesis in uraemia (author's transl)]. Dtsch Med Wochenschr (1973) 0.89
PDGF and TGF-beta contribute to the natural course of human IgA glomerulonephritis. Kidney Int (1995) 0.89
Bleeding in uremic patients after carbenicillin. Thromb Haemost (1976) 0.89
Dialysis membranes and coagulation system. Blood Purif (1986) 0.88
Rosiglitazone reduces angiotensin II and advanced glycation end product-dependent sustained nuclear factor-kappaB activation in cultured human proximal tubular epithelial cells. Horm Metab Res (2008) 0.88
Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases. Scand J Rheumatol (2007) 0.88